Effect of artesunate and mefloquine in combination on the Fridericia corrected QT intervals inPlasmodium falciparuminfected adults from Thailand
Open Access
- 10 January 2011
- journal article
- research article
- Published by Wiley in Tropical Medicine & International Health
- Vol. 16 (4) , 458-465
Abstract
Summary: Objective To ascertain whether mefloquine (MQ) produces electrocardiogram (ECG) changes that could be a risk for Torsades de Pointe (TdP), a potentially malignant, ventricular tachyarrhythmia.Methods We measured the Fridericia corrected QT (QTcF) intervals on 12 lead ECGs on days (D) 0, 3, 7 inPlasmodium falciparuminfected adults, treated with oral artesunate (AS) and MQ as a new fixed dose (n = 25) combination or loose tablets (n = 25) over 3 days. Target total doses were 12 mg/kg of AS and 24–25 mg/kg of MQ. MQ concentrations ([MQ]) were measured by HPLC.Results All ECG intervals were similar between drug arms and were combined for analysis. Mean QTcF values were 389 (D0), 407 (D3) and 399 (D7) ms (Ps < 0.003vs.D0); corresponding heart rates and [MQ]s were 83, 67 and 73 beats/minute (Ps≤0.0003vs.D0) and 0, 3095 and 1721 ng/ml. One male patient (loose arm) had a D3 QTcF 504 ms (D0 406 ms, D7 433 ms). In the modelling of QTcF and JTcF from D0 to D7, significant effects were observed individually for [MQ], temperature and heart rate (HR). The MQ AUC0‐∞was not a significant factor. Using a manual descending, model building approach to select variables, the HR was the only significant variable (P = 0.001) over time in the model that best explained the changes in the QTcF and JTcF intervals.Conclusions In this small group of patients, slowing heart rates due to malaria resolution best explained the observed increases in the QTcF intervals.Keywords
This publication has 27 references indexed in Scilit:
- New Fixed-Dose Artesunate-Mefloquine Formulation against Multidrug-Resistant Plasmodium falciparum in Adults: a Comparative Phase IIb Safety and Pharmacokinetic Study with Standard-Dose Nonfixed Artesunate plus MefloquineAntimicrobial Agents and Chemotherapy, 2010
- Use of weight-for-age-data to optimize tablet strength and dosing regimens for a new fixed-dose artesunate-amodiaquine combination for treating falciparum malaria2006
- Population Pharmacokinetic Assessment of a New Regimen of Mefloquine Used in Combination Treatment of Uncomplicated Falciparum MalariaAntimicrobial Agents and Chemotherapy, 2006
- Measurement and interpretation of QT dispersionProgress in Cardiovascular Diseases, 2000
- Halofantrine-associated Ventricular Fibrillation in a Young Woman with no Predisposing QTc ProlongationScandinavian Journal of Infectious Diseases, 1997
- Atrial flutter with 1: 1 conduction after administration of the antimalarial drug mefloquineClinical Cardiology, 1996
- Cardiac complications of halofantrine: a prospective study of 20 patientsTransactions of the Royal Society of Tropical Medicine and Hygiene, 1995
- A mechanistic link between an inherited and an acquird cardiac arrthytmia: HERG encodes the IKr potassium channelCell, 1995
- A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndromeCell, 1995
- Cardiac effects of antimalarial treatment with halofantrineThe Lancet, 1993